Stefan Offermanns is the director of the Max Planck Institute for Heart and Lung Research in Bad Nauheim, Germany. The Professor of Pharmacology and former director of the Institute of Pharmacology at the University of Heidelberg holds an MD degree from the Free University (FU) Berlin. Professor Offermanns worked as a Post-Doc in Pharmacology in Berlin and at the California Institute of Technology, Pasadena/CA. In 1997, he was appointed group leader at the Institute of Pharmacology of the FU Berlin, then became a Heisenberg Scholar in 1999 before moving on to Heidelberg in 2000. His field of interest includes cellular and biological functions of G-protein-mediated signal transduction processes in the cardiovascular and nervous system, regulation of cellular functions via members of the plexin B family, and the characterization of new G-protein-coupled receptors / G-protein-coupled receptors as pharmacological targets.Walter Rosenthal is the President of the Friedrich-Schiller-University of Jena, Germany, and former director of Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Leibniz Institute for Molecular Pharmacology and Professor for Molecular Pharmacology at the Charité University Hospital in Berlin. He is a medical doctor by training (Gießen/Germany, London) and held positions at the Universities of Heidelberg, Berlin and Gießen, and at Baylor College of Medicine, Houston/TX. Walter Rosenthal is interested in intracellular protein trafficking, scaffolding proteins, G-protein-coupled receptors, cAMP/PKA-triggered pathways, aquaporins, molecular defects underlying human disease, and pharmacological interference.

• The easy to use A–Z format provides easy access to relevant information in the form of standardized entries. For the third edition, entries on many completely new topics have been added.

Stefan Offermanns is the director of the Max Planck Institute for Heart and Lung Research in Bad Nauheim, Germany. The Professor of Pharmacology and former director of the Institute of Pharmacology at the University of Heidelberg holds an MD degree from the Free University (FU) Berlin. Professor Offermanns worked as a Post-Doc in Pharmacology in Berlin and at the California Institute of Technology, Pasadena/CA. In 1997, he was appointed group leader at the Institute of Pharmacology of the FU Berlin, then became a Heisenberg Scholar in 1999 before moving on to Heidelberg in 2000. His field of interest includes cellular and biological functions of G-protein-mediated signal transduction processes in the cardiovascular and nervous system, regulation of cellular functions via members of the plexin B family, and the characterization of new G-protein-coupled receptors / G-protein-coupled receptors as pharmacological targets.Walter Rosenthal is the President of the Friedrich-Schiller-University of Jena, Germany, and former director of Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Leibniz Institute for Molecular Pharmacology and Professor for Molecular Pharmacology at the Charité University Hospital in Berlin. He is a medical doctor by training (Gießen/Germany, London) and held positions at the Universities of Heidelberg, Berlin and Gießen, and at Baylor College of Medicine, Houston/TX. Walter Rosenthal is interested in intracellular protein trafficking, scaffolding proteins, G-protein-coupled receptors, cAMP/PKA-triggered pathways, aquaporins, molecular defects underlying human disease, and pharmacological interference.

• The easy to use A–Z format provides easy access to relevant information in the form of standardized entries. For the third edition, entries on many completely new topics have been added.